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INTRODUCTION
Several breast diseases could arise at any stage of the woman life, 
from menarche to menopause, during pregnancy or breastfeeding, and 
in the postmenopausal period (1). Among these conditions, some are 
extremely rare. Pseudoangiomatous stromal hyperplasia (PASH) is a 
benign proliferation of the breast tissue that typically affects women in 
the reproductive age and presents as a localized, painless, firm mass 
or as a diffuse thickened area (2). PASH typically appears as a solid, 
well defined, hypoechoic, noncalcified mass in the breast, visualized on 
ultrasound or mammography (3). However, it may rarely arise from the 
anogenital mammary-like tissue, simulating angiosarcomas (4) or other 
types of sarcomas (5,6). Therefore, PASH requires differential diagnosis 
of tissue sample. We present a case of nodular PASH arising in the vulva 
in a patient with recurrent PASH of the breast.
CASE PRESENTATION
A 23-year-old women with no history of pregnancy or child delivery 
(G0P0) presented an enlarging left vulvar mass with rapid growth. She 
had a long, complex medical history related to systemic lupus erythema-
tous (SLE) complicated by lupus nephritis, pemphigus vulgaris, chronic 
hypertension, and anemia. Moreover, she had undergone breast reduction 
two times due to rapid and painful bilateral enlargement of the breast 
caused by recurrent PASH. She denied use of oral contraceptives, which 
are known to play a key role on breast modifications (7, 8).
About 6 months prior to the gynecologic examination patient identified 
vulvar mass that has enlarged rapidly causing worsening pain, discomfort 
and inability to have intercourse. Patient was not pregnant at the time of 
examination. At the exam, there was an 8×4 cm non-tender mobile mass 
deforming the left labia majora, with a wide base, soft consistency, and 
no signs of infection (Figure 1 a-c). She underwent uneventful wide local 
surgical excision. Pathology results revealed scant fibro adipose tissue 
with chronic inflammation, edema and underlying spindle cell proliferation 
that were positive for D2-40 and weakly positive for CD31 by immuno-
histochemistry (Figures 2 and 3). Patient had uneventful recovery with 
excellent cosmetic healing of the incision. The patient was disease free at 
the 6 months follow-up after the excision.
DISCUSSION
Our case describes a rapid enlarging vulvar tumor in a young patient with 
a history of recurrent PASH of the breast. PASH is a benign hyperplastic 
condition typical of the breast. It is the result of the stromal myofibro-
blasts hyperplasia in response to hormonal stimuli and is characterized 
by complex channels with a spindle cell lining (9–12). It is extremely 
rare in the vulva and probably arises from the anogenital mammary-like 
glands (AGMLG) tissue. Accessory breast tissue can be found anywhere 
along the milk line, from the axilla to the groin (13). Initially considered 
ectopic breast tissue, AGMLG tissue is considered a normal part of the 
anogenital area (14). Histologically, it appears with slit-like spaces in the 
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Figure 1. Macroscopic aspects of the lesion: a) large rubbery firm mobile mass 
arising from left vulvar region; b) post-surgical wide local excision; c) macroscopic 
appearance of the lesion. Note the dark-white and glistening area with firm rubbery 
texture.
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stroma between glandular units, simulating vascular lesions. The spaces 
are outlined by proliferative myofibroblasts with nuclei that resemble 
endothelial cell nuclei, typically without atypia or mitotic activity in a col-
lagenous stroma (9). The myofibroblasts in PASH are variably reactive 
for CD34 and SMA, but negative for factor VIII, and rarely positive for 
CD31 (15), similarly to what occurs during epigenetic changes for atypi-
cal myomas (16). In contrast to previous cases reported in the literature 
(4), our case has several aspects that stand out and are worth mention-
ing. First, the unusual young age of the patient because majority of PASH 
of the vulva is described in perimenopausal patients. On that basis, our 
case suggests that the PASH of the vulva can present at any age after 
menarche (17), and this is important to consider when encountering a 
young patient with a vulvar mass. Second unusual aspect of this case 
was the size and the growth of the mass. Although majority of PASH 
patients present with small and slow growing tumors (1 to 2 cm), our 
patient presented with a 8 cm rapidly enlarging mass (18) which can 
easily be mistaken for angiosarcoma. Moreover, PASH can mimic vas-
cular structure of angiosarcomai.e. (angiosarcomas are characterized 
by true vascular channels lined by epithelium while PASH has pseudo 
vascular spaces devoid of red blood cells) (19). Lastly, the specimen 
resulted positive to CD31, which although rare is consistent with PASH. 
The histological differential diagnosis of PASH in the anogenital area is 
the same as in the breast (2, 20), and most commonly is the low grade 
angiosarcoma (21).
We believe this was the first case presenting with recurrent massive 
breast enlargement followed by anogenital lesion in a young premeno-
pausal patient. It remains unknown if there was a link between PASH of 
the breast and the risk of developing anogenital or other ectopic lesions. 
Awareness of vulvar PASH can be helpful specially to avoid unnecessary 
wide mutilating surgical procedures. 
CONCLUSION
PASH of the vulva is a rare benign tumor resulting from the proliferation 
of breast tissue, that can arise all along the embryonic milk line of the 
anogenital region. It can be mistaken for angiosarcoma raising clinical 
concern for malignancy. Awareness of this entity will assist the clinician in 
the diagnosis of this uncommon condition avoiding unnecessary aggres-
sive excisional surgical procedures. 
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